In vivo effects of recombinant IL-2. I. Isolation of circulating Leu-19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2

Journal of Immunology

Volumn 140, Issue 4, 1988, Pages 1335-1340

  McMannis, J D ^a   Fisher, R I ^a   Creekmore, S P ^a   Braun, D P ^a   Harris, J E ^a   Ellis, T M ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; MEMBRANE ANTIGEN;

CASE REPORT; CELL CULTURE; COLON CARCINOMA; HUMAN; HUMAN CELL; LYMPHOKINE ACTIVATED KILLER CELL; MELANOMA;

ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; CARCINOMA; CELL DIFFERENTIATION; COLONIC NEOPLASMS; CYTOTOXICITY TESTS, IMMUNOLOGIC; HUMAN; INTERLEUKIN-2; KILLER CELLS; MELANOMA; PHENOTYPE; RECOMBINANT PROTEINS;

EID: 0023868619     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)